Literature DB >> 9705586

Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.

R Zivadinov1, A Jurjevic, K Willheim, G Cazzato, M Zorzon.   

Abstract

For the period 1976 through 1996, we carried out an incidence and prevalence study of myasthenia gravis in the County of the Coast and Gorski kotar, Croatia. This was the first epidemiological study of myasthenia gravis in Croatia. A total of 43 incident cases were identified. Overall the average crude annual incidence rate was 6.52 per 1,000,000 person-years; 5.59 per 1,000,000 person-years for men and 7.41 per 1,000,000 person-years for women. The incidence rate was 6.30 (95% confidence intervals 4.56-8.51), age-adjusted to the European population and 5.17 (95% confidence intervals 3.74-6.98), age-adjusted to the world population. On 31 December 1996, there were 32 prevalent cases. The crude prevalence was 99 per 1,000,000 population (95% confidence intervals 67.7-139.6). The prevalence adjusted to the European and world populations was 101.9 (95% confidence intervals 69.7-143.7) and 75.9 (95% confidence intervals 51.9-107) per 1,000,000 population, respectively. Our incidence findings are similar to those reported in North-East Italy but lower than those in the United States. Our prevalence findings were generally higher than those in Northern European Countries but lower than those in the United States. Standardization of rates to the European or world population could facilitate comparison between different populations.

Entities:  

Mesh:

Year:  1998        PMID: 9705586     DOI: 10.1159/000026179

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

Review 1.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

2.  A population based epidemiological study on myasthenia gravis in Estonia.

Authors:  M Oöpik; A-E Kaasik; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 3.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

4.  Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.

Authors:  Claudia Sardu; Eleonora Cocco; Alessandra Mereu; Roberta Massa; Alessandro Cuccu; Maria Giovanna Marrosu; Paolo Contu
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

5.  Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.

Authors:  Sreenivasa Rao Sudulagunta; Mona Sepehrar; Mahesh Babu Sodalagunta; Aravinda Settikere Nataraju; Shiva Kumar Bangalore Raja; Deepak Sathyanarayana; Siddharth Gummadi; Hemanth Kumar Burra
Journal:  Ger Med Sci       Date:  2016-10-13

6.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.